20 results
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
19 Apr 24
Report of Foreign Private Issuer
7:00am
with PIRA as measured by positron emission tomography (PET) imaging via radiology marker [F-18]PBR06-PET, a novel, long-half-life ligand used in PET
6-K
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
the attenuation of microglial activation in patients with non-active secondary progressive multiple sclerosis (na-SPMS) based on positron emission
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
on positron emission tomography (PET) imaging and disease stabilization in na-SPMS patients with disease progression independent of relapse (PIRA).
Gabriele … on microglial activation in na-SPMS patients with PIRA as measured by positron emission tomography (PET) imaging via [F-18]PBR06-PET, a novel, long-half-life
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
of this disease.
In June:
The Company announced a reduction in microglial activation as seen in three-month Positron Emission Tomography (PET) scans - in a total … , as seen in six-month Positron Emission Tomography (PET) scans, has now been observed in a total of five of the six patients with non-active
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
13 Oct 23
Report of Foreign Private Issuer
7:00am
routes of drug delivery, today announced that a reduction in activated microglia, as seen in six-month Positron Emission Tomography (PET) scans, has now
6-K
s1ph4p v2a8
13 Oct 23
Report of Foreign Private Issuer
7:00am
424B5
cmr9by19ia5vb3 yw2
1 Sep 23
Prospectus supplement for primary offering
5:16pm
6-K
EX-99.1
edvilaomoon6
5 Jun 23
Report of Foreign Private Issuer
10:29am
6-K
EX-99.1
1sugkp7mtlxk
5 Apr 22
Report of Foreign Private Issuer
7:00am
6-K
EX-99.1
ma9 u87z0r
10 Mar 22
Report of Foreign Private Issuer
7:00am
6-K/A
EX-99.1
3t4k8
22 Feb 22
Interim Results for the Six Months Ended 30 June 2021
8:12am
6-K
EX-99.1
349kky4
10 Jan 22
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
aehifg dyp307
24 Sep 21
Notes to the Interim Financial Statements
1:59pm
6-K
EX-99.1
fzj8tl gkzmov3z5
25 May 21
Report of Foreign Private Issuer
6:05am
6-K
EX-10.2
tnia3uphfxzcnuetng
4 Aug 20
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
4:26pm
6-K
EX-1.1
n8vknl01
14 Apr 20
Current report (foreign)
8:46am
F-1
EX-1.1
0qkqlg95bd
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
EX-1.1
umy29
17 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next